InvestorsHub Logo

Bill B

05/08/21 1:31 PM

#339066 RE: rafunrafun #339061

Just that the original hls trial from last year posited a potential anti viral effect from vascepa and the trial results were positive.

http://hlstherapeutics.investorroom.com/2020-12-14-HLS-Therapeutics-Reports-Efficacy-and-Safety-Results-from-Pilot-Study-Treating-COVID-19-Infected-Outpatients-with-Vascepa-R-Icosapent-Ethyl

The method of action of vascepa in covid is still to be determined but it is proving to reduce inflammation.